Varenhorst, Christoph http://orcid.org/0000-0002-8378-3869
Lindholm, Martin
Sarno, Giovanna
Olivecrona, Göran
Jensen, Ulf
Nilsson, Johan
Carlsson, Jörg
James, Stefan
Lagerqvist, Bo
Funding for this research was provided by:
Uppsala Clinical Research Center
Article History
Received: 6 September 2017
Accepted: 9 April 2018
First Online: 17 April 2018
Conflict of interest
: C.V. reports during the conduct of this work, institutional research grants from AstraZeneca and The Medicines Company, lecture and advisory board fees from AstraZeneca, The Medicines Company and Boeringer Ingelheim, lecture fees from Bayer, CSL Behring, Bristol Myers Squibb, and Pfizer and is on the Clinical Endpoint Committee for Pfizer, Bristol Myers Squibb, Philips and AstraZeneca. At the time of resubmission of a revised version of this manuscript C.V reports being a Pfizer employee. M.L. reports no conflicts of interest. G.S. reports institutional research grant from Boston Scientific. G.O. reports physician proctor for Edwards Lifesciences and EPS Vascular, lecture fees from Biotronik, BBraun, advisory board fees for Vascular Solutions and is on the Clinical Endpoint Committee for Biosensors. U.J reports no conflicts of interest. J.N. reports no conflicts of interest. J.C. reports lecture fees from BBraun. S.J. reports institutional research grants and honoraria from Boston Scientific, Abbot vascular and Biotronic. B.L reports institutional grant from AstraZeneca.